Close

ChromaDex (CDXC) PT Raised 90% to $17 at Oppenheimer

March 12, 2021 9:05 AM EST Send to a Friend
Oppenheimer analyst Brian Nagel raised the price target on ChromaDex (NASDAQ: CDXC) to $17.00 (from $9.00) after the company announced ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login